Quality assessment of a serum and xenofree medium for the expansion of human GMP-grade mesenchymal stromal cells
Background Cell-based therapies are emerging as a viable modality to treat challenging diseases, resulting in an increasing demand for their large-scale, high-quality production. Production facilities face the issue of batch-to-batch consistency while producing a safe and efficient cell-based produc...
Main Authors: | Clotilde Aussel, Elodie Busson, Helene Vantomme, Juliette Peltzer, Christophe Martinaud |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2022-05-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/13391.pdf |
Similar Items
-
Inactivated Platelet Lysate Supports the Proliferation and Immunomodulant Characteristics of Mesenchymal Stromal Cells in GMP Culture Conditions
by: Katia Mareschi, et al.
Published: (2020-07-01) -
A Novel Xeno-Free Method to Isolate Human Endometrial Mesenchymal Stromal Cells (E-MSCs) in Good Manufacturing Practice (GMP) Conditions
by: Stefano Canosa, et al.
Published: (2022-02-01) -
Platelet-derived extracellular vesicles promote osteoinduction of mesenchymal stromal cells
by: Miquel Antich-Rosselló, et al.
Published: (2020-10-01) -
A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions
by: Katia Mareschi, et al.
Published: (2022-03-01) -
Genetic profiling of human bone marrow mesenchymal stromal cells after in vitro expansion in clinical grade human platelet lysate
by: Ann De Becker, et al.
Published: (2022-10-01)